Immunoassay

Details Immunoassay Immunoassay

2007-11-13

2009-12-29

Gabel, Gailene R (Department: 1641)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

C435S007100, C435S007920, C435S962000, C435S967000, C435S973000, C436S518000, C436S524000, C436S528000, C436S540000, C436S546000, C436S548000, C436S172000, C436S175000, C530S403000

Reexamination Certificate

active

07638292

ABSTRACT:
A method for detection and/or quantification of cardiac troponin I (cTnI) in a sample derived from an individual's blood, the method being based on a sandwich immunoassay employing at least two capture antibodies and at least one tracer antibody, in which a first capture antibody is directed to the N-terminal part of cTnI, to the C-terminal part of cTnI or to the part of the cTnI midfragment, which is slightly affected by the interfering factor, and a second capture antibody is directed to another of these parts, and a tracer antibody is directed to the N-terminal part of cTnI, to the C-terminal part of cTnI or to TnC, which is complexed with cTnI.

REFERENCES:
patent: 6114180 (2000-09-01), Doth et al.
patent: 2004/0018577 (2004-01-01), Campbell et al.
patent: WO 97/49994 (1997-12-01), None
patent: WO 99/64868 (1999-12-01), None
Katrukha et al., Degradation of cardiac troponin I: implication for reliable immunodetection, Clinical Chemistry 44 (12): 2433-2440 (1998).
Oh et al., Use of a Dual Monoclonal Sold Phase and a Polyclonal Detector to Create an Immunoassay for the Detection of Human Cardiac Troponin I, Clinical Biochemistry 33: 255-260 (Jun. 2000).
Eric Davies et al., “Analytical Performance and Clinical Utility of a Sensitive Immunoassay for Determination of Human Cardiac Troponin I”,Clinical Biochemistry30:6, 479-490 (1997).
Gaelle Ferrieres et al., “Human Cardiac Troponin I: Precise Identification of Antigenic Epitopes and Prediction of Secondary Structure”,Clinical Chemistry44:3, 487-493 (1998).
Susann Eriksson et al., “Negative Interference in Cardiac Troponin I Immunoassays from a Frequently Occurring Serum and Plasma Component”,Clinical Chemistry49:7, 1095-1104 (2003).
Se-Kyung Oh et al., “Use of a Dual Monoclonal Solid Phase and a Polyclonal Detector to Create an Immunoassay for the Detection of Human Cardiac Troponin I”,Clinical Biochemistry33:4, 255-263 (2000).
Giuliani et al., “Determination of Cardiac Troponin I Forms in the Blood of Patients with Acute Myocardial Infarction and Patients Receiving Crystalloid or Cold Blood Cardioplegia,” 45Clin.Chem. 213-222 (1999).
Katrukha et al., “Troponin I is Released in Bloodstream of Patients with Acute Myocardial Infarction Not in Free Form But as Complex,” 43Clin.Chem. 1379-1385 (1997).
Bohner et al., “False-Negative Immunoassay Results for Cardiac Troponin I Probably Due to Circulating Troponin I Antibodies,” 42Clin.Chem. 2046 (1996).
Oh et al., Use of a Dual Monoclonal Sold Phase and a Polyclonal Detector to Create an Immunoassay for the Detection of Human Cardiac Troponin I,Clinical Biochemistry33:255-260 (Jun. 2000).
Katrukha et al., “Degradation of Cardiac Troponin I: Implication for Reliable Immunodetection”,Clin.Chem. 44: 2433-2440 (1998).
Cardiac markers section of BiosPacific on-line catalog, http://www.biospacific.com/cardiac.html) Cardiac Markers section—as provided in IDS.

Affiliated with

Also associated with

Rating

Immunoassay does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunoassay, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunoassay will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4145663